Atlas Trials

A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas

Clinical trial NCT00001430 · COMPLETED

Trial details

NCT number
NCT00001430
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hodgkin's DiseaseNon Hodgkin's Lymphoma
Start date
1995-02-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.